SE9501472D0 - Truncated IGF-I - Google Patents

Truncated IGF-I

Info

Publication number
SE9501472D0
SE9501472D0 SE9501472A SE9501472A SE9501472D0 SE 9501472 D0 SE9501472 D0 SE 9501472D0 SE 9501472 A SE9501472 A SE 9501472A SE 9501472 A SE9501472 A SE 9501472A SE 9501472 D0 SE9501472 D0 SE 9501472D0
Authority
SE
Sweden
Prior art keywords
igf
truncated
truncated variant
expressing
variant
Prior art date
Application number
SE9501472A
Other languages
English (en)
Inventor
Rolf Eriksson
Stig Johansson
Harriet Roennholm
Anna Skottner
Karin Sonesson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9501472A priority Critical patent/SE9501472D0/sv
Publication of SE9501472D0 publication Critical patent/SE9501472D0/sv
Priority to AU54129/96A priority patent/AU5412996A/en
Priority to PCT/SE1996/000520 priority patent/WO1996033216A1/en
Priority to IL11790796A priority patent/IL117907A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SE9501472A 1995-04-21 1995-04-21 Truncated IGF-I SE9501472D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9501472A SE9501472D0 (sv) 1995-04-21 1995-04-21 Truncated IGF-I
AU54129/96A AU5412996A (en) 1995-04-21 1996-04-19 Truncated igf-i
PCT/SE1996/000520 WO1996033216A1 (en) 1995-04-21 1996-04-19 Truncated igf-i
IL11790796A IL117907A0 (en) 1995-04-21 1996-05-14 Truncated IGF-I

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501472A SE9501472D0 (sv) 1995-04-21 1995-04-21 Truncated IGF-I

Publications (1)

Publication Number Publication Date
SE9501472D0 true SE9501472D0 (sv) 1995-04-21

Family

ID=20398031

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9501472A SE9501472D0 (sv) 1995-04-21 1995-04-21 Truncated IGF-I

Country Status (4)

Country Link
AU (1) AU5412996A (sv)
IL (1) IL117907A0 (sv)
SE (1) SE9501472D0 (sv)
WO (1) WO1996033216A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
SE9802938D0 (sv) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
ES2329220T3 (es) 1999-01-06 2009-11-24 Genentech, Inc. Variantes mutantes del factor de crecimiento similar a insulina (igf) i.
EP1141014B1 (en) 1999-01-06 2004-12-08 Genentech, Inc. Insulin-like growth factor (igf) i mutant variant
JP2003502383A (ja) * 1999-06-21 2003-01-21 マードック チルドレンズ リサーチ インスティチュート 医学的障害の予防及び／又は治療のための方法
EP1282437B1 (en) 2000-05-16 2008-03-19 Genentech, Inc. Treatment of cartilage disorders
AU2002255508B2 (en) 2001-02-09 2008-04-03 Genentech, Inc. Crystallization of IGF-1
JP4117731B2 (ja) 2001-03-14 2008-07-16 ジェネンテック・インコーポレーテッド Ｉｇｆアンタゴニストペプチド
NZ545940A (en) 2003-09-12 2009-12-24 Tercica Inc Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency
WO2021005604A1 (en) 2019-07-11 2021-01-14 Opko Biologics Ltd. Long-acting igf-1 or igf-1 variants and methods of producing same
GB201913196D0 (en) 2019-09-12 2019-10-30 Univ Newcastle Culture method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
GB9217696D0 (en) * 1992-08-20 1992-09-30 Agricultural & Food Res Use of specific binding molecules
SE9402332D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab Igf-1

Also Published As

Publication number Publication date
AU5412996A (en) 1996-11-07
IL117907A0 (en) 1996-08-04
WO1996033216A1 (en) 1996-10-24

Similar Documents

Publication Publication Date Title
DK0770139T3 (da) En svamp, hvor areA-genet er blevet modificeret, samt et areA-gen fra aspergillus oryzae
SE9501472D0 (sv) Truncated IGF-I
AU4200897A (en) Novel host cells and methods of producing proteins
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
AU4981101A (en) Subtilisin variants
IL157644A0 (en) Method for the purification of a protein preparation with erythropoietin activity
EP0088195A3 (en) Messenger rna, production and use thereof
AU8131294A (en) Human kunitz-type protease inhibitors
ES8506348A1 (es) Procedimiento para producir la subunidad b de la toxina del colera
ATE234933T1 (de) Verfahren zur herstellung von d-aminosäuren durch direkte gärung
WO1996022371A3 (en) C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
AU3802595A (en) Tripeptidyl aminopeptidase
ES2169225T3 (es) Micro-organismo tolerante del estres y procedimiento de produccion de producto de fermentacion.
AU4940096A (en) Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production
ATE85345T1 (de) Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
AU7811000A (en) Membrane translocating peptide drug delivery system
BR0014519A (pt) Sequências de sinais para a preparação de leu-herudin através da secreção por e. coli no meio de cultura
PL348669A1 (en) Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
HUP0203221A2 (hu) A lignin bioszintézisében résztvevő enzimeket kódoló gének és alkalmazásuk
WO1997009420A3 (en) Dna sequences coding for a human metalloproteinase and variants thereof
AUPM772494A0 (en) Improvements in production of proteins in host cells
AU6378994A (en) Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter
EP2298911A3 (en) Methods for producing polypeptides in respiratory-deficient cells
AU4944996A (en) Dna fragment encoding d-amino acid oxidase